Prospects for pharmacotherapy of schizophrenia

This publication has 45 references indexed in Scilit:

• Idazoxan, an ??2 Antagonist, Augments Fluphenazine in
  Journal of Clinical Psychopharmacology, 1993
• The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
  The British Journal of Psychiatry, 1993
• In vivo studies of [125I]iodobenzamide and [11C]iodobenzamide: A ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D2 dopamine receptors
  Synapse, 1992
• Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action
  Molecular and Cellular Neuroscience, 1992
• Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
  The Lancet, 1992
• The Effects of Clozapine on Tardive Dyskinesia
  The British Journal of Psychiatry, 1991
• Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compound
  Drug Development Research, 1991
• Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicentre trial programme
  Acta Psychiatrica Scandinavica, 1990
• Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons
  Science, 1983
• Antipsychotic drug doses and neuroleptic/dopamine receptors
  Nature, 1976